Evidence map›Paper›PMID 19273309›Full record

ReviewFrontiers in bioscience (Landmark edition)2009

Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation.

Karen L Wood, Homer L Twigg, Andrea I Doseff

Abstract readReview
In one paragraph

Review in Frontiers in bioscience (Landmark edition), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Co-inhibitory profile and cytotoxicity of CD57Clinical and experimental immunology · 2018
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. A FasFrontiers in immunology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer.Molecular therapy : the journal of the American Society of Gene Therapy · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karen L WoodDepartment of Medicine, The Ohio State University Medical Center, Columbus, OH, USA. karen.wood@osumc.edu
Homer L Twigg
Andrea I Doseff

Funding

Molecular Mechanisms of Apoptosis in MonocytesR01HL075040 · NHLBI · OHIO STATE UNIVERSITY · PI DOSEFF, ANDREA · 2006 to 2010
$1.9M
PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTIONR01HL059834 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TWIGG, HOMER L · 1998 to 2002
$736k
Lung Alloimmunity after Bone Marrow TransplantationK08HL080701 · NHLBI · OHIO STATE UNIVERSITY · PI WOOD, KAREN · 2005 to 2009
$653k
NHLBI NIH HHS K08 HL080701NHLBI NIH HHS R01 HL075040NHLBI NIH HHS R01 HL075040-01NHLBI NIH HHS R01 HL59834
6 · The paper itself

Abstract

Expansion of CD8+ lymphocyte subsets are found in many states with chronic antigenic exposure including HIV, multiple myeloma, rheumatoid arthritis, CMV infection, transplantation and even normal aging. These expansions are characterized by the expression of CD57 antigen and the loss of CD28-. These lymphocytes are thought to represent clonally expanded cytotoxic T lymphocytes (CTL) that have become senescent and lack proliferative ability. These cells also demonstrate suppressive properties and have been linked with immunodeficiency raising the question of the function of these cells in relationship to immunoregulation. Alterations in the CD95/Fas apoptotic pathway and changes in pro-survival factors such as Hsp27 likely contribute to this lymphocyte subset expansion. Further understanding of the normal CD8+ lymphocyte response to antigen and the factors that lead to abnormal continued expansion in certain disease states will be crucial to understanding the pathogenesis of chronic antigenic stimulation.

Indexed as

ApoptosisCD57 AntigensCD8-Positive T-LymphocytesCell ProliferationCellular SenescenceChronic DiseaseHumansCD57 Antigens

Identifiers

PMID19273309
PMCPMC2740383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.